Molecular Basis of Oncogenic PI3K Proteins DOI Open Access
Zhi Sheng, Patrick J. Beck,

Maegan Gabby

и другие.

Cancers, Год журнала: 2024, Номер 17(1), С. 77 - 77

Опубликована: Дек. 30, 2024

The dysregulation of phosphatidylinositol 3-kinase (PI3K) signaling plays a pivotal role in driving neoplastic transformation by promoting uncontrolled cell survival and proliferation. This oncogenic activity is primarily caused mutations that are frequently found PI3K genes constitutively activate the pathway. However, tumorigenesis can also arise from nonmutated proteins adopting unique active conformations, further complicating understanding PI3K-driven cancers. Recent structural studies have illuminated functional divergence among highly homologous proteins, revealing how subtle alterations significantly impact their contribute to tumorigenesis. In this review, we summarize current knowledge Class I aim unravel complex mechanism underlying traits. These insights will not only enhance our PI3K-mediated oncogenesis but pave way for design novel PI3K-based therapies combat cancers driven

Язык: Английский

The Molecular Mechanisms of Bergapten Against Abdominal Aortic Aneurysm: Evidence From Network Pharmacology, Molecular Docking/Dynamics, and Experimental Validation DOI Open Access

Fujia Xu,

Sihan Luo, Zhenhua Huang

и другие.

Journal of Cellular Biochemistry, Год журнала: 2025, Номер 126(4)

Опубликована: Март 30, 2025

ABSTRACT This study endeavors to assess the potential protective role of bergapten (BP) in mitigating abdominal aortic aneurysm (AAA) and decipher underlying mechanisms molecular targets. Network pharmacology was utilized search for targets BP against AAA. Molecular docking dynamics simulations were validate interaction with core targets, then therapeutic effect mechanism on AAA verified by using an elastase‐induced model. analysis identified five pharmacological BP, including EGFR, SRC, PIK3CA, PIK3CB, JAK2. further prioritized JAK2 as most promising candidate treatment The results animal experiments demonstrated that significantly reduced expression inflammatory cytokines IL‐6, TNF‐α, IL‐1β tissue mouse model, inhibited phosphorylation STAT3. plays important AAA, it may become a drug combat progression. inhibitory vascular progression attenuation cell infiltration be related regulation JAK2/STAT3 signaling pathway.

Язык: Английский

Процитировано

0

Molecular Basis of Oncogenic PI3K Proteins DOI Open Access
Zhi Sheng, Patrick J. Beck,

Maegan Gabby

и другие.

Cancers, Год журнала: 2024, Номер 17(1), С. 77 - 77

Опубликована: Дек. 30, 2024

The dysregulation of phosphatidylinositol 3-kinase (PI3K) signaling plays a pivotal role in driving neoplastic transformation by promoting uncontrolled cell survival and proliferation. This oncogenic activity is primarily caused mutations that are frequently found PI3K genes constitutively activate the pathway. However, tumorigenesis can also arise from nonmutated proteins adopting unique active conformations, further complicating understanding PI3K-driven cancers. Recent structural studies have illuminated functional divergence among highly homologous proteins, revealing how subtle alterations significantly impact their contribute to tumorigenesis. In this review, we summarize current knowledge Class I aim unravel complex mechanism underlying traits. These insights will not only enhance our PI3K-mediated oncogenesis but pave way for design novel PI3K-based therapies combat cancers driven

Язык: Английский

Процитировано

0